A research team led by Dr. Juyeon Jung at the Bio-Nano Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), has developed a nanobody-based technology that can precisely identify and attack only lung cancer cells, opening new possibilities for cancer therapy.

This study examines how catastrophic health expenditure (CHE) affects health-related quality of life (HRQoL) in patients with chronic diseases, highlighting the moderating role of family doctor contract services. It finds that patients experiencing CHE had significantly lower HRQoL scores compared to those without, but family doctor services helped mitigate these negative effects. Older age, multiple chronic conditions, and higher healthcare utilization were linked to poorer HRQoL, while higher education and stable employment offered protective benefits. The study suggests that expanding family doctor services for chronic disease patients can help break the "poverty-disease" cycle and improve overall health outcomes.

Extracellular vesicles (EVs) are tiny particles released by cells that help control egg development. In a recent review, researchers from China explored how EVs influence oocyte health by transferring important molecules between cells. The article discusses how EV function changes under disease conditions and how this affects fertility. It also highlights the growing potential of therapeutic EVs to improve egg quality and treat ovarian disorders, offering new possibilities for advancing reproductive medicine.

A landmark mini-review from Peking Union Medical College Hospital delivers a snapshot of nine PD-1/IL-2 bi-functional drugs now in clinical trials. By silencing PD-1 and selectively fueling T cells with refined IL-2 in one molecule, these agents reinvigorate exhausted immune soldiers while sparing healthy tissue, promising safer and broader cancer cures.